openPR Logo
Press release

Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market: A Study of the Sector's Present Situation and Prospects Forecast 2026

05-25-2023 08:11 PM CET | Health & Medicine

Press release from: MarkNtel Advisors LLP

Artificial Intelligence (AI) Enabled Drug Discovery

The "Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Size, Share, Analysis, Future, Overview, Outlook, Forecast 2026" research report, released by MarkNtel Advisors, offers a thorough examination of the industry's past, present, and projected trends. The report is the result of a meticulous analysis of growth drivers, limitations, opportunities, challenges, and demand scenarios, aimed at assisting stakeholders in making informed investment decisions in the Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market. It is anticipated that the market will experience an approximate 23.6% compound annual growth rate (CAGR) from 2021 to 2026.
The report contains in-depth data regarding the present and projected size and growth rate of the market anticipated in the forecast period. The research study takes into account the historical period of 2016-19, with 2020 being the base year.
The analysts have offered objective and verified insights using graphs and tables, with the primary goal of providing key stakeholders with a more comprehensive industry outlook. These factors will aid stakeholders in enhancing their visibility and making informed strategic decisions for the future.
The comprehensive aspects mentioned in the report are the result of thorough research conducted by our researchers, utilizing tools such as Porter's Five Forces model. This approach allows us to study and comprehend the crucial factors influencing the fluctuations in industry growth. Additionally, stakeholders can discover detailed insights regarding the attractiveness of the Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market, including a clear analysis of the most and least opportune segments in various geographic locations.
Get Your Complimentary Sample Report Now! https://www.marknteladvisors.com/query/request-sample/artificial-intelligence-enabled-drug-discovery-clinical-trials.html
Note: The team of Analyst at MarkNtel Advisors performs relentless primary & secondary investigation with industry experts to present an impartial & exhaustive examination of industries.
In-depth Examination of Segmentation in the Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market
Our report encompasses a comprehensive assessment of the fragmented divisions within the Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market, considering the historical, current, and projected future trends. These factors play a crucial role in providing stakeholders with a clear understanding of the key elements driving market growth during 2021-26. The research report profiles various market segmentations, which are listed below:
Based on Component
- Software
- Service
Based on Application
- Data Aggregation and Analysis
- Clinical Trials
- Drug Design
- Drug Characterization
- Biomarker Research
Based on Therapeutic Application
- Oncology
- Cardiovascular Disease
- Nervous System Disease
- Respiratory Disorder
- Metabolic Disorder
- Immunologic Disease
- Infectious Disease
- Others
Based on End Users
- Biopharmaceutical Industry
- Contract Research Organization (CROs)
- Academic Institutes and Research Centers
Market Division by Region or Country-
- North America
- South America
- Europe
- Asia-Pacific
- Middle East & Africa
Immerse Yourself in the Complete Report: Explore Extensive Research, Market Segmentation, and Competitive Landscape Analysis - https://www.marknteladvisors.com/research-library/artificial-intelligence-enabled-drug-discovery-clinical-trials.html
Analysis of the Competitive Landscape in the Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market
This section presents information on the competitive landscape of major companies operating in the Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market. It includes details on recent developments, marketing strategies, product portfolios, expansions, revenue generation, supply chain models, and more. Additionally, it provides insights into collaborations, partnerships, mergers and acquisitions, as well as the impact of new entrants on market growth. The following prominent players are participating in the industry:
- Accutar Biotechnology
- Ardigen
- Atomwise Inc.
- AiCure, LLC
- Berg LLc
- Cloud Pharmaceuticals
- Biovista
- Cyclica Inc.
- Symphony Innovations
- GNS Healthcare
The analysis highlights the activities and contributions of these key players within the market.
Explore the Report's Framework: Get Oriented with the Table of Contents for a Clear Understanding
-Market Segmentation
-Introduction
-Executive Summary
-Market Porters Five Forces Analysis
-Market Technological Changes
-Market Trends & Insights
-Market Dynamics
Top Reasons to Buy the Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Research Report:
• The research report titled "Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Analysis, 2026" assists stakeholders in formulating strategies for business growth by examining market dynamics such as trends, developments, drivers, restraints, opportunities, challenges, and more. The report provides valuable insights that enable stakeholders to make informed decisions and plan their future endeavours in the market.
• The analysis aims to provide stakeholders with insightful data on the upcoming competition in the industry, enabling them to make informed decisions and develop strategies accordingly. It offers valuable information that assists stakeholders in understanding the competitive landscape and preparing for the challenges ahead.
• The study also discusses various partnerships, collaborations, mergers and acquisitions, licensing activities, as well as political scenarios, and the prominent players associated with the Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market. It provides comprehensive insights into the strategic alliances and regulatory landscape that impact the market dynamics. Additionally, the report highlights the key players driving the market and their respective roles within the industry.
• This comprehensive report showcases the various sustainability practices adopted by companies across different segments and geographic locations to drive significant revenue generation. It provides valuable insights into the diverse strategies employed by each company to achieve sustainable growth and profitability.
• This research report evaluates the Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market and provides information on performance indicators that could potentially impact the industry's growth trajectory during 2021-26
• . It offers valuable insights into key factors that may influence the market's direction and growth trends.
Get the Solution that Fits: Explore Customization Services for Your Unique Requirements - https://www.marknteladvisors.com/query/request-customization/artificial-intelligence-enabled-drug-discovery-clinical-trials.html

Media Representative
Company Name: MarkNtel Advisors
Email: sales@marknteladvisors.com
Phone: +1 628 895 8081 +91 120 4268433,
Address: 5214F Diamond Heights Blvd #3092,
San Francisco, CA 94131 
United States

ABOUT US:
MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

Using such information, our clients can identify attractive investment opportunities & strategize their moves to yield higher ROI (Return of Interest) through an early mover advantage with top-management approaches.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market: A Study of the Sector's Present Situation and Prospects Forecast 2026 here

News-ID: 3067141 • Views:

More Releases from MarkNtel Advisors LLP

GCC Ginger Market Revenue Expected to Reach USD 122 Million by 2030 | Major Players Include Agthia Group and Al Islami Foods
GCC Ginger Market Revenue Expected to Reach USD 122 Million by 2030 | Major Play …
Executive Summary The GCC Ginger Market is poised for robust growth, driven by increasing health consciousness and a diverse expatriate population. Valued at approximately USD 88.29 million in 2025, the market is projected to reach USD 122 million by 2030, reflecting a Compound Annual Growth Rate (CAGR) of 6.68% from 2025 to 2030. Key government initiatives aiming at promoting healthier lifestyles further bolster this trend, positioning ginger as a staple in
Asia-Pacific Ginger Market to Reach USD 2.55 Billion by 2030 | Key Players Included: Allana Group, Buderim Ginger Ltd., and Mane Kancor
Asia-Pacific Ginger Market to Reach USD 2.55 Billion by 2030 | Key Players Inclu …
Executive Summary The Asia-Pacific Ginger Market is poised for significant growth, with a projected size of USD 2.55 billion by 2030, up from USD 1.89 billion in 2025. This growth trajectory reflects a compound annual growth rate (CAGR) of 6.17% from 2025 to 2030, driven by increasing consumer awareness about health benefits, government support initiatives, and a growing demand for organic products. The region's climatic advantages further enhance ginger cultivation, ensuring
Rental & Pay-as-Use Models Reshape North America Used Truck Market
Rental & Pay-as-Use Models Reshape North America Used Truck Market
The North America Used Truck Market is undergoing a significant transformation, projected to escalate from approximately USD 16.1 billion in 2024 to a staggering USD 24.43 billion by 2030. This growth, equating to a compound annual growth rate (CAGR) of around 7.20% from 2025 to 2030, highlights the dynamic landscape within which rentals and pay-as-use models are emerging as game-changers in the industry. North America Used Truck Market Outlook The dramatic increase

More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase